David M. Epstein, SEE REMARKS at Black Diamond Therapeutics, Inc. (BDTX), sold 25,000 shares at $6.70 ($168K) on 2023-06-27, disclosed to the SEC on 2023-06-28.
Scheduled sale ($168k) by SEE REMARKS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BDTX | SELL | 2020-11-03 | $745K | — | Filing → |
| BDTX | SELL | 2020-10-02 | $364K | — | Filing → |